mianserin has been researched along with mdl 100907 in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (15.79) | 18.2507 |
2000's | 7 (36.84) | 29.6817 |
2010's | 8 (42.11) | 24.3611 |
2020's | 1 (5.26) | 2.80 |
Authors | Studies |
---|---|
Benwell, K; Bickerdike, M; Kennett, G; Knight, AR; Misra, A; Quirk, K; Revell, D | 1 |
Griebel, G; Perrault, G; Sanger, DJ | 1 |
Dekeyne, A; Girardon, S; Millan, MJ | 1 |
Alsayegh, L; Backstrom, JR; Berry, SA; Friedman, L; Roth, BL; Sanders-Bush, E; Willins, DL | 1 |
Matsumoto, K; Morishige, R; Murakami, Y; Sakakibara, I; Takayama, H; Tohda, M; Watanabe, H | 1 |
Abreu, GR; Bissoli, NS; Cabral, AM; Pires, JG; Ramage, AG; Silva, AL | 1 |
Bhagwagar, Z; Cowen, PJ; Cunningham, VJ; Grasby, PM; Hinz, R | 1 |
Alfinito, PD; Cosmi, S; Deecher, DC; Maswood, N; Pawlyk, AC | 1 |
Carley, DW; Olopade, C; Radulovacki, M; Ruigt, GS | 1 |
Ceccherini-Nelli, L; Focosi, D; Kast, RE; Lauria, G; Maggi, F; Petrini, M | 1 |
Chesselet, MF; De Deurwaerdère, P; Le Moine, C | 1 |
Bhagwagar, Z; Cowen, PJ; Cunningham, VJ; Grasby, PM; Hinz, R; Meyer, PT | 1 |
Poyurovsky, M | 1 |
Foley, JJ; Walker, EA | 1 |
Farrell, M; Rosenzweig-Lipson, S; Walker, E | 1 |
Iwamura, T; Kasai, M; Kato, S; Nisijima, K; Shioda, K; Yoshino, T | 1 |
Atzori, C; Bonora, S; Busolli, P; Calcagno, A; Ghisetti, V; Imperiale, D; Trentalange, A | 1 |
El-Tanbouly, DM; Sayed, RH; Wadie, W | 1 |
Bucki, A; Czopek, A; Filipek, B; Kołaczkowski, M; Kubacka, M; Pawłowski, M; Siwek, A | 1 |
1 trial(s) available for mianserin and mdl 100907
Article | Year |
---|---|
Efficacy of mirtazapine in obstructive sleep apnea syndrome.
Topics: Administration, Oral; Adolescent; Adult; Aged; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Polysomnography; Serotonin 5-HT2 Receptor Antagonists; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Sleep Apnea, Obstructive | 2007 |
18 other study(ies) available for mianserin and mdl 100907
Article | Year |
---|---|
Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
Topics: Binding Sites; Binding, Competitive; Cell Line; Humans; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Recombinant Proteins; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2004 |
A comparative study of the effects of selective and non-selective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Diazepam; Drinking; Fluorobenzenes; Indoles; Male; Maze Learning; Mianserin; Mice; Mice, Inbred BALB C; Piperidines; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin Antagonists | 1997 |
Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO 60-0175: a pharmacological analysis.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aminopyridines; Animals; Conditioning, Operant; Ethylamines; Fluorobenzenes; Indoles; Male; Mianserin; Piperazines; Piperidines; Pyrazines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Reinforcement, Psychology; Serotonin Antagonists; Serotonin Receptor Agonists; Thiophenes | 1999 |
Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo.
Topics: 3T3 Cells; Animals; Antipsychotic Agents; Benzodiazepines; Cell Line; Clozapine; Dendrites; Fluorobenzenes; Haloperidol; Mianserin; Mice; Olanzapine; Piperidines; Pirenzepine; Prefrontal Cortex; Pyramidal Cells; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Recombinant Proteins; Risperidone; Ritanserin; Serotonin Antagonists; Transfection | 1999 |
Suppressive effects of isorhynchophylline on 5-HT2A receptor function in the brain: behavioural and electrophysiological studies.
Topics: Alkaloids; Aminopyridines; Animals; Behavior, Animal; Brain; Dose-Response Relationship, Drug; Female; Indole Alkaloids; Ketanserin; Male; Membrane Potentials; Methoxydimethyltryptamines; Mianserin; Mice; Mice, Inbred ICR; Motor Activity; Oocytes; Oxindoles; Patch-Clamp Techniques; Piperazines; Rats; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Xenopus | 2005 |
Chronic treatment with mianserin prevents DOCA-salt hypertension in rats--evidence for the involvement of central 5-HT2 receptors.
Topics: Animals; Blood Pressure; Desoxycorticosterone; Dose-Response Relationship, Drug; Drinking; Heart Rate; Hypertension; Injections, Intraventricular; Male; Mianserin; Rats; Rats, Wistar; Receptors, Serotonin, 5-HT2; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Sodium; Time Factors; Urodynamics; Weight Gain | 2005 |
Validation of a tracer kinetic model for the quantification of 5-HT(2A) receptors in human brain with [(11)C]MDL 100,907.
Topics: Adult; Antidepressive Agents; Brain; Brain Chemistry; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Data Interpretation, Statistical; Female; Fluorobenzenes; Humans; Image Processing, Computer-Assisted; Kinetics; Magnetic Resonance Imaging; Male; Mianserin; Middle Aged; Mirtazapine; Models, Neurological; Models, Statistical; Piperidines; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, Serotonin, 5-HT2A; Reproducibility of Results; Serotonin Antagonists; Spectrophotometry, Ultraviolet | 2007 |
Effects of the 5-HT2A antagonist mirtazapine in rat models of thermoregulation.
Topics: Animals; Body Temperature Regulation; Dose-Response Relationship, Drug; Female; Hot Flashes; Mianserin; Mirtazapine; Ovariectomy; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists | 2006 |
5-HT2a inhibitors for progressive multifocal leukoencephalopathy: old drugs for an old disease.
Topics: Adult; Female; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Male; Mianserin; Middle Aged; Mirtazapine; Polycythemia Vera; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists | 2008 |
Selective blockade of serotonin 2C receptor enhances Fos expression specifically in the striatum and the subthalamic nucleus within the basal ganglia.
Topics: Animals; Corpus Striatum; Globus Pallidus; Indoles; Male; Mianserin; Photomicrography; Proto-Oncogene Proteins c-fos; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Substantia Nigra; Subthalamic Nucleus | 2010 |
Simplified quantification of 5-HT2A receptors in the human brain with [11C]MDL 100,907 PET and non-invasive kinetic analyses.
Topics: Adult; Brain; Brain Mapping; Carbon Radioisotopes; Female; Fluorobenzenes; Humans; Kinetics; Linear Models; Male; Mianserin; Middle Aged; Mirtazapine; Models, Neurological; Piperidines; Positron-Emission Tomography; Receptor, Serotonin, 5-HT2A; Serotonin Agents; Signal Processing, Computer-Assisted | 2010 |
Acute antipsychotic-induced akathisia revisited.
Topics: Acute Disease; Akathisia, Drug-Induced; Antipsychotic Agents; Humans; Mianserin; Mirtazapine; Practice Guidelines as Topic; Serotonin 5-HT2 Receptor Antagonists | 2010 |
Acquisition session length modulates consolidation effects produced by 5-HT2C ligands in a mouse autoshaping-operant procedure.
Topics: Animals; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Inverse Agonism; Drug Partial Agonism; Indoles; Ligands; Lysergic Acid Diethylamide; Male; Memory; Methysergide; Mianserin; Mice; Piperazines; Pyrazines; Pyridines; Reinforcement Schedule; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors | 2010 |
Discriminative stimulus effects of serotonin agonists, neutral antagonists, and inverse agonists in pigeons: perspectives on intrinsic efficacy measurements in vivo.
Topics: Animals; Columbidae; Discrimination Learning; Dose-Response Relationship, Drug; Drug Inverse Agonism; Male; Methysergide; Mianserin; Pyrazines; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2010 |
The effects of mirtazapine and fluoxetine on hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
Topics: Animals; Antidepressive Agents, Tricyclic; Disease Models, Animal; Fever; Fluoxetine; Male; Mianserin; Mirtazapine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar; Serotonin 5-HT2 Receptor Antagonists; Serotonin Agents | 2011 |
Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosis.
Topics: Aged; DNA, Viral; Female; Humans; Immunosuppressive Agents; JC Virus; Leukoencephalopathy, Progressive Multifocal; Mianserin; Mirtazapine; Sarcoidosis; Serotonin 5-HT2 Receptor Antagonists | 2016 |
Modulation of TGF-β/Smad and ERK signaling pathways mediates the anti-fibrotic effect of mirtazapine in mice.
Topics: Animals; Antioxidants; Collagen; Glutathione; Hepatic Stellate Cells; Hypertension, Portal; Lipid Peroxidation; Liver; Liver Cirrhosis, Experimental; Male; Mianserin; Mice; Mirtazapine; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; Oxidative Stress; Phosphorylation; Protein Kinase C; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Signal Transduction; Smad3 Protein; Thioacetamide; Transforming Growth Factor beta1 | 2017 |
Novel serotonin 5-HT
Topics: Animals; Aorta; CHO Cells; Cricetinae; Cricetulus; Humans; Hydantoins; Mianserin; Models, Molecular; Molecular Structure; Platelet Aggregation Inhibitors; Protein Conformation; Rats; Serotonin 5-HT2 Receptor Antagonists | 2021 |